Connect® MM- The Multiple Myeloma Disease Registry
Stopped early
Conditions studied: Multiple Myeloma
In brief
The purpose of the Connect® MM Registry is to explore the natural history and real world management of patients with newly diagnosed symptomatic multiple myeloma (MM) and provide unique insights into the management of MM and the impact of this hematologic disorder on patients.
Key facts
- Study ID
- NCT01081028
- Run by
- Celgene
- People needed
- 3011
- Starts
- 2009-09-01
- Expected to finish
- 2024-12-31
- Last updated by the study team
- 2026-04-13
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Cohort 1 and 2
- Newly diagnosed with symptomatic MM within 2 months of enrollment in Connect® MM registry
- Age ≥18 years
- Willing and able to provide signed informed consent
- Agrees to complete patient assessment questionnaires either alone or with minimal assistance from caregivers and/or trained site personnel
- Cohort 3
- Received 1L therapy for symptomatic active MM and subsequently has evidence of disease progression. Prior 1L MM treatment received, including anti-myeloma therapy, transplant, chemotherapy, radiation, and surgery, must be known.
- Initiated or intends to initiate 2L systemic therapy for MM after the first documented relapsed/refractory date (i.e. 1L PD).
- Enrollment date must be within 90 days of start date (or intended start date) of 2L systemic therapy.
You may not qualify if…
- Cohort 1 and 2
- None
- Cohort 3
- Patient's 1L MM treatment was for smoldering MM or MGUS, and not for symptomatic MM
- Currently active in any MM Registry, including but not limited to, the Connect® MM registry or another Celgene/BMS-Sponsored registry.
- Patients who have discontinued from Connect® MM or another Celgene/BMS-Sponsored registry could be considered for enrollment in Cohort 3, if inclusion and exclusion criteria are met.
- Currently enrolled or intending to enroll within 90 days in any interventional clinical trial in which any treatment is an investigational product that cannot be identified
Where it is running
- DCH Health System — Tuscaloosa, Alabama, United States
- US Oncology - Arizona Oncology Associates - Rudasill — Tucson, Arizona, United States
- St. Edward Mercy Medical Center — Fort Smith, Arkansas, United States
- Genesis Cancer Center — Hot Springs, Arkansas, United States
- Clopton Clinic Hematology/Oncology — Jonesboro, Arkansas, United States
- Little Rock Hematology Oncology Associates, PA — Little Rock, Arkansas, United States
- Pacific Cancer Medical Center, Inc — Anaheim, California, United States
- Alta Bates Summit Comprehensive Cancer Center — Berkeley, California, United States
- Southbay Oncology Hematology Partners — Campbell, California, United States
- Compassionate Cancer Care Medical Group (Corona) — Corona, California, United States
- Southwest Cancer Care — Escondido, California, United States
- Compassionate Cancer Care Medical Group (Fountain Valley) — Fountain Valley, California, United States
- Virginia K. Crosson Cancer Center — Fullerton, California, United States
- TORI - Antelope Valley Cancer Center — Lancaster, California, United States
- Monterey Bay Oncology — Monterey, California, United States
- TORI - North Valley Hematology/Oncology — Northridge, California, United States
- Hematology Oncology Associates — Oakland, California, United States
- Comprehensive Cancer Center — Palm Springs, California, United States
- Bay Area Cancer Research Group, LLC — Pleasant Hill, California, United States
- New Hope Cancer & Research Institute — Pomona, California, United States
- Campassionate Cancer Care Medical Group (Riverside) — Riverside, California, United States
- Capitol Hematology Oncology Medical Group - Sutter Roseville — Roseville, California, United States
- TORI - Central Coast Medical Oncology — Santa Maria, California, United States
- Redwood Regional Medical Group, Inc. — Santa Rosa, California, United States
- The Cancer Center of Huntsville — Huntsville, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.